Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder. The infantile form is the most common genetic cause of infantile death due to respiratory insufficiency. The disorder is caused by the premature death of motor neurons of anterior horn, leading to progressive weakness and muscular atrophy. Longtime considered as untreatable, the pathology knew a real revolution during the last two years. Views on this terrible disease have completely changed, changing, therefore, the management of the patients and constituting new challenges.

Type

Journal article

Publication Date

2019-02-01T00:00:00+00:00

Volume

74

Pages

82 - 85

Total pages

3

Keywords

Newborn screening, Treatments, Spinal muscular atrophy, Humans, Infant, Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood, Survival of Motor Neuron 1 Protein